Arrhythmias, Cardiac  >>  rivaroxaban  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rivaroxaban / Generic mfg.
NCT01812200 / 2012-001814-41: Antithrombotic Triple Therapy in Humans

Completed
4
60
Europe
Dabigatran, Ticagrelor, ASA, Rivaroxaban, Ticagrelor, ASA, Phenprocoumon, Ticagrelor, ASA
Medical University of Vienna
Atrial Fibrillation, Acute Coronary Syndrome
05/13
07/13
NCT01747746: Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study

Completed
4
33
US
Rivaroxaban, Xarelto, Warfarin and Enoxaparin, Coumadin
John H. Stroger Hospital, Cook County Hospital
Atrial Fibrillation, Stroke, Thrombo-embolism, Bleeding
10/14
10/14
NCT01706146: Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring

Completed
4
59
US, Canada
Non-coumadin Oral Anticoagulant, Including but not limited to:, Dabigatran (Pradaxa), Rivaroxaban (Xarelto), Apixaban (Eliquis)
Northwestern University, National Heart, Lung, and Blood Institute (NHLBI), Medtronic
Atrial Fibrillation
02/15
02/15
NCT02996435: Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation

Completed
4
139
US
Mobile Application Intervention, Care4Today®, No Intervention
Janssen Scientific Affairs, LLC
Atrial Fibrillation
03/18
03/18

Download Options